RESULTS: Seventy-four (74) patients in the PATHways group were compared with 54 patients in the control group. Demographic characteristics were similar. PATHways patients were significantly less likely to experience the composite outcome than the control group (77% vs 94.4%, P¼0.007). PATHways group compared to controls significantly less frequently required morphine for NAS (23% vs. 44.4%, P¼0.01) and hospital stay > 5days (58.1% vs. 92.6%, P<0.0001) ( Table 1) . Pathways group compared to controls had significantly shorter hospital stay (11 AE 9.9 days vs. 15 AE 10.9 days, P¼0.048), were on significantly lower buprenorphine dose (12 AE 5 mg vs. 16 AE 6 mg, P¼ 0.005) and required significantly less morphine (0.09 AE 0.1 mg/kg/dose vs. 0.16 AE 0.06 mg/kg/dose, P¼0.004) ( was included; women with pre-existing psychiatric conditions were excluded. ICD-9-CM diagnosis codes identified birth type and psychiatric conditions from 9 months prior (for exclusion) to delivery until one year after delivery. The primary outcome was presentation to the ED or hospital within one year of delivery for management of severe psychiatric morbidity, measured via a composite including: suicide attempt, depression, anxiety, posttraumatic stress disorder (PTSD), acute stress reaction, or adjustment disorder. Secondary outcomes included individual measures of the composite and a substance use composite (drug or alcohol use or dependence). We compared outcomes after stillbirth !23 weeks to those after term, liveborn singletons using multivariable logistic regression to adjust for mode of delivery and maternal age, race, health insurance type, and income quartile. RESULTS: 8245 women with stillbirth and 1,207,280 with term, singleton livebirth were included. Within one year of stillbirth, 3.4% of women had severe psychiatric morbidity: the odds were 2.5 times higher compared to those with livebirth (adjusted odds ratio (aOR) 2.5 (95% confidence interval (CI) 2.22 e 2.82). With the exception of acute stress reaction, each condition within the psychiatric composite was associated with significantly higher odds of severe psychiatric morbidity in the year after delivery in women with stillbirth compared to livebirth, particularly for adjustment disorder (aOR 4.90 (95%CI 3.40 e 7.08)) and PTSD (aOR 4.31 (95% CI 2.29 e 8.10)). After stillbirth, women also had significantly higher odds of presenting to the ED or hospital for substance use (aOR 2.38 (95% CI 1.95 e 2.91)). CONCLUSION: Delivering a stillbirth is associated with increased risk of severe psychiatric morbidity and substance use in the following year, suggesting women who have a stillbirth may benefit from additional psycho-social support for up to a year after their delivery.
OBJECTIVE: To determine whether women without preexisting psychiatric conditions have higher odds of severe psychiatric morbidity in the year after stillbirth versus term, singleton livebirth. STUDY DESIGN: This retrospective cohort study used the Florida State Inpatient and State Emergency Department (ED) Databases. The first delivery of all Florida residents aged 13 to 55 years old from 2005 to 2013 was included; women with pre-existing psychiatric conditions were excluded. ICD-9-CM diagnosis codes identified birth type and psychiatric conditions from 9 months prior (for exclusion) to delivery until one year after delivery. The primary outcome was presentation to the ED or hospital within one year of delivery for management of severe psychiatric morbidity, measured via a composite including: suicide attempt, depression, anxiety, posttraumatic stress disorder (PTSD), acute stress reaction, or adjustment disorder. Secondary outcomes included individual measures of the composite and a substance use composite (drug or alcohol use or dependence). We compared outcomes after stillbirth !23 weeks to those after term, liveborn singletons using multivariable logistic regression to adjust for mode of delivery and maternal age, race, health insurance type, and income quartile. RESULTS: 8245 women with stillbirth and 1,207,280 with term, singleton livebirth were included. Within one year of stillbirth, 3.4% of women had severe psychiatric morbidity: the odds were 2.5 times higher compared to those with livebirth (adjusted odds ratio (aOR) 2.5 (95% confidence interval (CI) 2.22 e 2.82). With the exception of acute stress reaction, each condition within the psychiatric composite was associated with significantly higher odds of severe psychiatric morbidity in the year after delivery in women with stillbirth compared to livebirth, particularly for adjustment disorder (aOR 4.90 (95%CI 3.40 e 7.08)) and PTSD (aOR 4.31 (95% CI 2.29 e 8.10)). After stillbirth, women also had significantly higher odds of presenting to the ED or hospital for substance use (aOR 2.38 (95% CI 1.95 e 2.91)). CONCLUSION: Delivering a stillbirth is associated with increased risk of severe psychiatric morbidity and substance use in the following year, suggesting women who have a stillbirth may benefit from additional psycho-social support for up to a year after their delivery.
122 Is delivering multiples associated with increased risk of severe psychiatric illness within the following year?
OBJECTIVE: The impact of multiples on acute postpartum psychiatric illness is unclear. We aimed to determine whether women without preexisting psychiatric conditions or intrapartum severe maternal morbidity (SMM) have higher odds of developing severe psychiatric morbidity in the year after delivering multiples versus term singletons. STUDY DESIGN: This retrospective cohort study used the Florida State Inpatient and State Emergency Department (ED) Databases. The first delivery of all Florida residents aged 13 to 55 years old from 2005 to 2013 was included; women with pre-existing psychiatric conditions or intrapartum SMM as defined by the CDC were excluded. ICD-9-CM diagnosis codes identified number of infants delivered, intrapartum SMM, and psychiatric conditions from 9 months prior to delivery (for exclusion) until 1 year after delivery. The primary outcome was presentation to the ED or hospital within a year of delivery for severe psychiatric morbidity, measured via a composite including: suicide attempt, depression, anxiety, posttraumatic stress disorder (PTSD), acute stress reaction, or adjustment disorder. Secondary outcomes included individual measures of the composite and a substance use composite (drug or alcohol use or dependence). We compared outcomes after delivery of liveborn multiple gestation to those after liveborn term singletons using logistic regression to adjust for mode of delivery and maternal age, race, health insurance type, and income quartile. RESULTS: 15,964 women with multiples and 1,182,572 women with term singletons were included. Within a year of delivering multiples without SMM, 2.1% of women had severe psychiatric morbidity: the odds were more than 50% times higher compared to women with term singletons without SMM (adjusted odds ratio (aOR) 1.58 (95% Confidence Interval (CI) 1.41 e 1.76)). Within the psychiatric composite, the conditions with highest odds of presenting to the ED or hospital in the year after multiples were PTSD (aOR 2.93 (95% CI 1.64 e 5.23)) and adjustment disorder (aOR 2.25 (95% CI 1.45 e 3.47)). After having multiples without SMM, women also had significantly higher odds of presenting to the ED or hospital for substance use (aOR 1.35 (95% CI 1.16 e 1.71)). CONCLUSION: Delivering multiples is associated with increased risk of severe psychiatric morbidity and substance use in the following year. These data suggest women who have multiples may need additional psychosocial support in the year after delivery.
123 Is severe intrapartum maternal morbidity associated with acute psychiatric illness within a year of delivery? OBJECTIVE: The impact of severe maternal morbidity (SMM) on postpartum psychiatric health is unknown. We aimed to determine whether women without preexisting psychiatric illness have higher odds of developing severe psychiatric morbidity in the year after term, singleton livebirth with versus without SMM. STUDY DESIGN: This retrospective cohort study used the Florida State Inpatient and State Emergency Department (ED) Databases. The first delivery of all Florida residents aged 13 to 55 years old from 2005 to 2013 was included; women with pre-existing psychiatric illness were excluded. ICD-9-CM diagnosis codes identified SMM (per CDC composite) and psychiatric conditions from nine months prior to delivery (for exclusion) until one year after delivery. The primary outcome was presentation to the ED or hospital within a year of delivery for severe psychiatric morbidity (composite of suicide attempt, depression, anxiety, post-traumatic stress disorder, acute stress reaction, or adjustment disorder) or substance use (drug or alcohol use or dependence). Secondary outcomes included psychiatric morbidity with individual measures of the SMM composite. We compared outcomes after term, singleton liveborn delivery with SMM versus without SMM using multivariable logistic regression adjusting for mode of delivery and maternal age, race, health insurance type, and income quartile. RESULTS: 16,698 women with SMM and 1,190,882 without SMM were included. Within a year of delivery with SMM, 3.0% of women had severe psychiatric morbidity: the odds were over two times higher compared to delivery without SMM (adjusted odds ratio (aOR) 2.04 (95% Confidence Interval (CI) 1.86 e 2.24)). SMM was associated with significantly higher odds of having individual conditions within the psychiatric composite, particularly adjustment disorder (aOR 2.80 (95% CI 1.99 e 3.94)) & depression (aOR 2.22 (95% CI 1.95 e 2.53)). Within the SMM composite, having acute myocardial infarction, acute renal failure, conversion of cardiac arrhythmia, sepsis, sickle cell crisis, & tracheostomy each had more than four times higher odds of severe psychiatric morbidity within a year of delivery compared to women who did not have these conditions. CONCLUSION: SMM during term, singleton delivery is associated with increased risk of severe psychiatric illness in the following year, particularly for certain morbidities. Women who have SMM may benefit from additional psychosocial support for at least a year after delivery.
